Nicholas Ollberding to Clinical Trials as Topic
This is a "connection" page, showing publications Nicholas Ollberding has written about Clinical Trials as Topic.
Connection Strength
0.019
-
A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas. Leuk Lymphoma. 2014 Jun; 55(6):1288-94.
Score: 0.019
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.